However, the selective mechanism of action of HDACi and ACY-738 in particular, could be due to the ALS model system, as ACY-738 (100 mg/kg) treatment prevented weight loss, improved grip strength, and prolonged survival in FUS-ALS mice [25]. This evidence concerns the gene FUS and amyotrophic lateral sclerosis.